JLM-BioCity Innovations

Concenter Biopharma Ltd. is developing a Promising Drug for Treating and Preventing Type 2 Diabetes (T2D)

Concenter Biopharma is working on a novel drug to eliminate type 2 diabetes with no side effects. The drug dramatically ...
Read More

SaliStick of Salignostics-the World’s First Saliva Rapid Pregnancy Test at Medica Expo, Germany

During the MEDICA exhibition in Düsseldorf, Germany, on November 18, Salignostics present for the first time the world's first saliva rapid pregnancy ...
Read More

Founders raise venture funding for peptide discovery product

Interview with Pepticom CEO Dr. Immanuel Lerner, and head of busdev Mayaan Maayan Elias Robicsek, Ph.D., MBA, BSc

PepDiscovery of Novel Peptide Drug Candidates by Artificial Intelligence Design. Interview conducted by Ben Woolf and Deborah Amsallem on 15th ...
Read More

Entera Bio recently entered into a $270 million license agreement with Amgen

Entera Bio's platform technology enables oral therapies based on molecules that would otherwise undergo gastric degradation and have limited or ...
Read More

Pepticom Raises $5 million in Series A Funding

Jerusalem based Pepticom, a leader in artificial intelligence peptide drug discovery, has secured $5 million in Series A funding from ...
Read More

Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel

Jerusalem-based Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, and Swiss Lonza (SWX: LONN), an integrated healthcare solutions provider, ...
Read More

Accellix signs Co-Development Agreement with Orgenesis

Agreement Integrates Accellix’s Proprietary Quality Control Optic System, Cartridges, Reagents and Software into Orgenesis’ Point of Care Cellular Therapy Platform ...
Read More

EU awards HIL Applied Medical with €2.5M in Grant Funding

The European Commission managing Horizon 2020 – the EU Framework Programme for Research and Innovation – approved HIL’s Phase-II proposal, ...
Read More

Atox Bio gets BARDA Support for Continued Development of Reltecimod for Necrotizing Soft Tissue Infections

Atox Bio, a late-stage clinical company developing immunotherapies for critically ill patients, announced that the Biomedical Advanced Research and Development ...
Read More

KAHR Medical Announces Clinical Trial Collaboration with ROCHE in Advanced Lung Cancer Patients

KAHR Medical Ltd , a biopharmaceutical company developing a novel drug platform based on bi-functional, immunotherapeutic fusion proteins known as ...
Read More

Betalin Therapeutics’s Micro Pancreas Ready for Human Trials

Betalin Therapeutics' Micro Pancreas will be tested on humans within 12 months. The biological pancreas contains living islet cells that ...
Read More

Future Meat Technologies raises $14m in Seed Funding

Israeli start-up Future Meat Technologies has secured $14 million in a seed funding round as it intends to build the ...
Read More

Carolina Partners Expands Treatment Offerings to Include Revolutionary Brainsway Therapy for OCD

Carolina Partners, one of the most prominent mental and behavioral practices in the country, announced plans to offer patients access ...
Read More

European Investment Bank VP Attends Signature Event at BiondVax Extending Financing to €24million

The Board of Directors and Management of BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), was honored to host Mr. Ambroise Fayolle, Vice-President ...
Read More

JLM-BioCity Pharma Diabetes "Oral Insulin"

Oramed Provides Clinical Update with Meaningful Data Expected by Year-End

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) , a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today provided a ...
Read More

JLM-BioCity BioInovation post “Father of Cannabis Research” Raphael Mechoulam

New York Arcview Investor Forum Honors “Father of Cannabis Research” Raphael Mechoulam with $10K Award

The Arcview Group will honor “The Father of Cannabis Research" with a Lifetime Achievement Award and a $10,000 research grant ...
Read More

JLM-BIOCITY Pharma Pharmaceutical Cannabis Marijuana

RAFA and Panaxia’s Medical Cannabis Oil examined by Israeli Ministry of Health

For the first time in Israeli history, The Israeli Ministry of Health will discuss including medical cannabis in the Health and Drug Baskets ...
Read More

RenalSense Receives new Innovation Authority $828,000 R&D Grant

The Israeli Ministry of Economy and Industry and the Israel Innovation Authority have funded over NIS 25 million ($6.9 million) in ...
Read More

RespiDx’s spin-off, OmnySense, commercializes its comprehensive remote checkups Multimometer

RespiDx has created a new spin-off, OmnySense, to commercialize its Multimometer for comprehensive remote checkups. RespiDx has developed a technology ...
Read More

FameWave Acquisition Marks Kitov’s Transition Into Oncology

Kitov Pharma recently contracted an arrangement to acquire FameWave Ltd. for a share exchange transaction. FameWave shareholders will receive $10M worth of newly ...
Read More

China’s Regulatory Authority [NMPA] Approves Oramed’s Oral Insulin Capsules IND Application

The Chinese partner of Oramed Pharmaceuticals Inc., Hefei Tianhui Incubator of Technologies Co., Ltd, has reached the significant regulatory milestone of approval of ...
Read More

Yarok Microbio combines Chemicals with AI to identify Dangerous Bacteria in Produce

Israeli startup Yarok Microbio says it has developed a way to identify life-threatening bacteria in as little as under an hour, before ...
Read More

Insulin Replacement Company Betalin Therapeutics Raises $2.5m

Israeli diabetes treatment developer Betalin Therapeutics has raised $2.5 million from leading venture capital funds and private investors for its revolutionary treatment, ...
Read More

Intec Pharma’s Pharmacokinetic Study of Accordion Pill™ Carbidopa/Levodopa 50/500 mg Dosed 3x Daily Report Positive Results

Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec")presented the preliminary results from a pharmacokinetic (PK) study comparing the Company's Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD) ...
Read More

Clinical Research on Medical Cannabis Inhalers by Rafa & Panaxia Pharmaceutical Industries to offer immediate Pain Relief to Cancer Patients

As a means of providing immediate pain relief for cancer patients, scientists are carrying out clinical research with Rafa and Panaxia, two ...
Read More

Hadasit, IBM set up digital health accelerator at Hadassah Ein Kerem, first startups already running

Hadasit, the Hadassah Medical Organization’s technology transfer company, has launched Israel’s first biotechnology hub within a medical center. Hadassah Accelerator ...
Read More

BIONDVAX Edges Closer to Elusive Universal Flu Vaccine

Jerusalem-based BiondVax Pharmaceuticals is edging closer to an unprecedented universal, multi-season and multi-strain flu vaccine capable of protecting all of ...
Read More

Cancer Treatment Company HIL to Set Up $5 Million Jerusalem Manufacture Center

Jerusalem-based cancer treatment company HIL Applied Medical Ltd. has signed an agreement to lease a 700 square-meter space from The ...
Read More

Copaxone Rival Mapi Pharma to Build Jerusalem Plant

Israeli drug discovery company Mapi Pharma, which has developed a delayed release version of Copaxone, Teva Pharmaceutical Industries Ltd. drug for ...
Read More

Video Clips from JLM-BioCity Event: Women Leaders in Bio

Video Clips from the JLM-BioCity Event: "Women Leaders in Bio: Fixing the Gender Imbalance in Healthcare Leadership” Held at Azrieli ...
Read More

BrainsWay has new Clinical Support Program for Physicians Treating Obsessive-Compulsive Disorder

BrainsWay Ltd. (TASE: BRIN), a global leader in the advanced non-invasive treatment of brain disorders, announced the initiation of “Launchpad ...
Read More

Blind reads Text, Recognizes Faces using Orcam’s MyEye on US TV program, “Doctors”

Fitzville Martin, AKA Fitz, blind since birth, appeared on US TV program, The Doctors to demonstrate the world’s most advanced ...
Read More

Future Meat Technologies raises $ 2.2 million for Lab grown Meat

Israeli biotech company, Future Meat Technologies, which develops lab-grown meat, raised $2.2 million last summer in a seed round led by ...
Read More

Jerusalem-based Air Doctor on Spanish 8madrid TV during their peak hour!

Air Doctor , a Jerusalem-based eHealth startup, provides a marketplace designed to match patients with specialized physicians while traveling. The Company’s platform helps ...
Read More

Lumir Lab, a Cannabis lab, set up at Hadassit on Hebrew U’s Ein Kerem campus

Israeli holding company Asana Bio Group, now taking its first steps towards growing cannabis in Malta, has invested $2.3 million ...
Read More

JLM-BioCity pharma biotech influenza flu

BiondVax’s Universal Flu Vaccine Featured on CNN

BiondVax's Universal Flu Vaccine was recently featured on CNN. They reported the following: Instead of relying on people to get ...
Read More

Novel Non-Invasive, Painless Low-Level Electromagnetic Radiation Device Targets Early Stage Cancer Tumors

SynergyMed Ltd, is a Jerusalem based medical device startup company that is focusing on the treatment of breast, head & ...
Read More

Novotalk won the first place at the RESI 2019 Innovation Challenge

In this year's highly competitive RESI (Redefining Early Stage Investments) Innovation Challenge, Novotalk was chosen in first place against many other ...
Read More

Diagnoz.me won the EHealth 2018!

Home diagnosis kit Jerusalem startup Diagnoz.me has a smartphone system that can detect infections from home and send results to your doctor. Founder ...
Read More

STEM CELL MEDICINE LICENSES EXOSOME TECHNOLOGY FOR TREATING AUTISM FROM RAMOT, TEL AVIV U

Stem Cell Medicine Ltd. (SCM), a Jerusalem-based biotechnology company developing new therapies for neurological indications, including mesenchymal stem cells and ...
Read More

JLM-BioCITY biomed diagnostics melonoma skin cancer

Scade Medical handheld Skin Cancer Diagnotics Scanner is raising funding for Clinical Trials

Scade Medical, (http://scademedical.com) was founded in 2013 by Dr. Ofir Aharon and Mr. Gabi Mizrahi along with first two investors ...
Read More

FDA Approves Teva’s First and Only Digital Inhaler with Built-In Sensors

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved ...
Read More

Point of Care Blood Test Co. Sight Diagnostics raises $28m on Start of Marketing of Malaria to Developing Countries

Sight Diagnostics (SightDX), a portfolio company of Anatomy, Clal Biotechnology's investment fund for medical devices, had raised $28 million. When ...
Read More

JLM-BioCity ehealth wearables diagnostics medical

Powermat Wireless Charging Founder Ran Poliakine Launches Innovation Center to Advance Early Stage Wearable Technologies

Ran Poliakine, founder and former CEO of Powermat, has established a new Innovation Center designed to foster and develop new and ...
Read More

JLM-BioCity Biomed ICU hospital renal monitoring

RenalSense Conducts Pilot Study on ICU Patient Monitoring at U of Pittsburgh Medical Center

RenalSense® is conducting a pilot study with its Clarity RMS® critical care monitoring system at the University of Pittsburgh Medical Center (UPMC), ...
Read More

JLM-BioCity Biotech Opiod addiction mental disorder

BrainsWay Selected for USA FDA Innovation Challenge to tackle Opioid Addiction

BrainsWay's deep transcranial magnetic stimulation (Deep TMS) system was one of only eight medical devices selected by the U.S. Food ...
Read More

JLM-BioCity Biotech computation artificialintelligence mmunology peptides drugdevelopment

Pepticom’s AI Discovered 53 Novel Immune-Mmodulators

Pepticom was honored with an image from their article on this December's Journal of Immunology. The image is taken from Pepticom's ...
Read More

Immunovative Therapies’ Next-Generation Cancer Vaccine Could Change the Game!

While current immunotherapies offer promise to previously untreatable cancers, they only work in a small percentage of patients with certain ...
Read More

Enlivex Therapeutics merged into NASDAQ-based Co-Bioblast Pharma Ltd, of Dahlia Meggido

Bioblast Pharma Ltd. (Nasdaq:ORPN) announced the execution of a definitive agreement to acquire Enlivex Therapeutics Ltd., a VC-funded privately-held immunotherapy ...
Read More

JLM-BioCity ehealth accelerator Hadassah Hadassit IBM

Hadasit & IBM set up digital health accelerator at Hadassah Ein Kerem, Jerusalem

Hadassah Medical Center in Jerusalem and IBM Israel have announced the establishment of a special accelerator for startups in which ...
Read More

Intec Pharma Reports Third Quarter 2018 Financial Results and Corporate Update

Completed enrollment in pivotal Phase 3 ACCORDANCE trial is on track for topline data in mid-2019 JERUSALEM, Nov. 9, 2018 /PRNewswire/ -- Intec Pharma ...
Read More

Entera Bio is a product-focused biotechnology company specializing in the oral delivery of large molecules and biologics

Positive results in Entera Bio’s pharmacokinetic (PK) & pharmacodynamic (PD) study in patients with hypoparathyroidism

Entera Bio Ltd. (Nasdaq: ENTX) announced today that it has received positive results from the first part of its pharmacokinetic (PK) ...
Read More

JLM-BioCIty pharma biotech flu influenza vaccine

The New Scientist Reports on Biondvax’s Universal Flu Vaccine

For decades, scientists have been trying to develop a universal vaccine that would protect people against seasonal flu for years, ...
Read More

Anchiano Therapeutics files for $30-40m Nasdaq offering

Jerusalem based cancer treatment company Anchiano Therapeutics (TASE: ANCN), formerly BioCancell Therapeutics, has announced the publication of a confidential prospectus for an ...
Read More

Results of Zion Medical’s First Human Clinical Trial of HIV drug Gammora Offers Potential Cure

Zion Medical, an Israeli biotech company developing HIV and cancer treatments, has announced the results of the first clinical trial ...
Read More

Hebrew U Researchers Develop Technology for 3-D Printing of Drugs

Researchers from Jerusalem’s Hebrew University unveiled their novel technology for three-dimensional printing of drug capsules on Wednesday, enabling the customization ...
Read More

JLM-based Gamida Cell to raise $69m in Nasdaq IPO/adds Robert Blum as new Chairman of the Board

Jerusalem stem cell cancer therapy developer Gamida Cell Ltd. has filed a registration statement on Form F-1 with the US ...
Read More

CDC sponsored study: Argaman Technologies reduced by 25% hospital acquired infections and by 40% Multi-Drug Resistant Organisms in Wards!

The University of Pennsylvania Medical School Hospital is to announce the results of a study on the impact of Argaman Technologies ...
Read More

Densys3D Announces US Dental Depot as Regional US Distributor

Densys3d has entered into a strategic agreement with US Dental Depot as a regional distributor for their intraoral scanner, MIA3D ...
Read More

Hadassah Hebrew U BioDesign Project, CardioVia, Raises NIS 3 Million & Was Accepted to the NGT3 VC Incubator

Following the June 2018 presentation of bio-med projects in the framework of the BioDesign, a joint program of Hadassah Medical ...
Read More

JLM-Biocity Biotech diagnostics oncology cancer

NovellusDx Inks Japan Distribution Deal for Cancer Treatment Response Assay

NovellusDx said today that it has signed a deal with Primetech to distribute its u Functional Annotation for Cancer Treatment (FACT) ...
Read More

Sight Diagnostics Offers an AI-based Diagnostics Device for Faster Blood Tests

Sight Diagnostics, an Israeli medical devices startup in Jerusalem that’s using computer vision and machine learning technology to speed up ...
Read More

JLM-BioCity Biomed Mental Health patient engegement

Behavioral Health Care Management Startup Valera Health adds Eau Claire Group Health Cooperative to Customer Base

Valera Health, a behavioral healthcare management startup that developed an app to help clinicians remotely monitor patients with anxiety and ...
Read More

NovaSight diagnoses and treats Lazy Eye and Concentration Problems by Monitoring Eye Movement

NovaSight system diagnoses eye problems in children and makes it possible to train the eyes in cases of amblyopia (lazy eye) ...
Read More

BrainsWay Receives First Ever FDA Clearance of a Non-Invasive Device for Treatment of Obsessive Compulsive Disorder

This clearance marks the second indication granted for BrainsWay Deep TMS. The first clearance was for treatment of Major Depressive ...
Read More

US Patent Office Grants NOVELLUSDX Patent for Methods & Systems for identifying Patient-Specific Driver Mutations

NovellusDx, the leader in functional genomics, was granted from the US Patenet Office a new patent titled “METHODS AND SYSTEMS ...
Read More

BiondVax receives second €6M tranche disbursement from the European Investment Bank (EIB)

BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), developer of M‑001, a clinical phase 3 Universal Influenza Vaccine candidate, recently announced the receipt ...
Read More

MonitHer ‘s New Home-Use Breast Cancer Detection Device Wins WeWork’s $360 K Creator Award

While Yehudit Abrams was working as a postdoctoral fellow at NASA, her job was to research the potential use of ...
Read More

Analytics Insights Selected BrainQ as One of the 10 Most Innovative Artificial Intelligence Solution Providers for 2018

Analytics Insight announced in their June digital magazine of that BrainQ is one of the most Innovative AI solution providers ...
Read More

JLM-Biocity Biotech Food Nutrition Vegan

Lab-Made Meat Startup SuperMeat raises $3M Seed to develop ‘Clean’ Chicken

SuperMeat, an Israeli biotech and food-tech startup that is developing lab-made chicken meat, raised early this year $3 million in ...
Read More

Cellect Signs Strategic Agreement with Swiss Biotech Center (SBC) & with Dresden University denovoMATRIX Team

Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced that it has entered into a ...
Read More

Oramed to be Added to Russell Microcap® Index

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery ...
Read More

JLM-BioCity Biomed visually impaired blind

Prince William exeriences Orcam’s Life Changing Device for Blind People

Prince William, the Duke of Cambridge, has made a truly historic first official visit of a member of the Royal ...
Read More

Mazor Robotics’ Renaissance System installed at Georgia ASC and at Advocate Lutheran General Hospital in Illinois

In June 2018, GNS Surgery Center, an affiliate of United Surgical Partners International, announced that it has completed their first ...
Read More

Jerusalem based Entera Bio Ltd. Announces Pricing of IPO for conducting Clinical Trials of Three Orally delivered Drugs targeting the Gastrointestinal Tract

Entera Bio Ltd. (NASDAQ:ENTX) (NASDAQ:ENTXW), a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule ...
Read More

Kadimastem has Upgraded its Manufacturing Site for Treatment of ALS Patients in the Clinical Trial

Kadimastem chose to upgrade the production rooms, for the treatment of ALS patients in the Phase 1 / 2a clinical ...
Read More

HIL Co-Founder and CTO, Prof. Arie Zigler, is a finalist for Berthold Leibinger Innovationspreis 2018

June, 2018 - Prof. Arie Zigler, HIL’s Co-Founder and CTO, and a faculty member of the Hebrew University's Physics Department, ...
Read More

Ayala Pharmaceuticals Presents Phase 1b Data at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting for AL101, a Pan-Notch Inhibitor, in Patients with Locally Advanced or Metastatic Solid Tumors

Positive Results Support Development Pathway of AL101 as a Targeted Therapy for Patients with Tumors That Have Activating Notch Mutations ...
Read More

Hebrew University Researchers to Collaborate With GRAIL on Methylation Data from Multiple Cell Types to understand How to interpret the Source of blood-based Signals

Yissum, the Technology Transfer Company of The Hebrew University of Jerusalem, announced a strategic collaboration with GRAIL, Inc., a healthcare company ...
Read More

Oramed Initiates a Food Effect Study for its Oral Insulin Capsule ORMD-0801

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced ...
Read More

Brainsway and Cohen Veterans Bioscience Collaborating in Biomarker Research for Post Traumatic Stress Disorder

Unique Biomarkers Sought to Enable Personalized Medicine Approach for Treatment of Post Traumatic Stress Disorder (PTSD) Brainsway Ltd.(BRIN.TA), a leader ...
Read More

JLM-BioCity Business Mission Netherlands

InnovationQuarter (NL) visits the Hebrew University BioGiv “Excubator” Infrastructure Center

June 7, 2018 - InnovationQuarter (NL) visited the @BioGiv “Excubator” Infrastructure Center of the Hebrew University at the Hitech Village on ...
Read More

VideoTherapy to present at the Summer Expo June 28, Cleveland, Ohio

In Spring 2018, Plug and Play Cleveland Innovation Platform began it's first inaugural Health & Wellness accelerator program. Plug and Play evaluated ...
Read More

Thomas Jefferson University announces Global Center in Jerusalem

June 6, 2018 - Thomas Jefferson University announced Tuesday, June 6 2018, the opening of the Jefferson Israel Center in Jerusalem ...
Read More

Jerusalem based 6Degrees “Computer Mouse for Amputees”

May 28, 2018 - 6Degrees is developing a unique algorithm that will be embedded within a line of products; the ...
Read More

Jerusalem-based Kitov Announces Commercialization Agreement for their Drug against Osteoarthritis Pain Consensi™ with China

June 3, 2018 - Kitov Pharma Ltd. (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, announced today that the Company has ...
Read More

Jerusalem-based Omnix Medical is developing Novel Antibiotic Agents Against Resistant Pathogenic Bacterial Strains

Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains. Omnix ...
Read More

Jerusalem-based startup Raziel Therapeutics developed an injectable molecule that melts away fat cells

The key to fighting obesity is through diet and lifestyle, experts agree. But a new “fat-melting” injection developed by an ...
Read More

Atox Bio Announces Enrollment of First Patient in Acute Kidney Injury (AKI) Phase 2 Study

May 30, 2018 - Atox Bio, a clinical stage biotechnology company developing novel therapies for critically ill patients, announced that the ...
Read More

BiondVax is carrying clinical trials out on their universal flu vaccine candidate M-001 in both the US and Europe

May 14 - BioWorld reported that BiondVax puts pegs in place for final push in universal flu vaccine effort http://www.bioworld.com/content/biondvax-puts-pegs-place-final-push-universal-flu-vaccine-effort . Clinical trials ...
Read More

BrainQ raises $5.3M to treat neurological disorders with the help of AI

May 15, 2018 - BrainQ, a Jerusalem-based digital therapeutics startup that aims to help stroke victims and those with spinal cord injuries ...
Read More

FDA Clearance Granted to BrainsWay for Next Generation Stimulator

May 7, 2018 - BrainsWay will now have the most advanced stimulator on the market, with enhanced features that increase the ...
Read More

Tyson leads $2.2m investment in JLM based Future Meat Technologies

May 2, 2018 - Jerusalem-based biotechnology company Future Meat Technologies has received $2.2 million in a seed investment funding round led ...
Read More

NovellusDx Completes $6M Equity Financing

April 30, 2018 - NovellusDx, a Jerusalem, Israel-based functional genomics company, completed a $6m equity financing. Backers in the round, ...
Read More

VRHealth selected for Excellence in Healthcare Future Tech Award at 2018 Las Vegas Smart Health Conference

April 27, 2018 - The Smart Health Conference in Las Vegas has selected VRHealth, the Israel-based, virtual reality for physical therapy technology ...
Read More

Cordis and Medinol Announce First U.S. Commercial Implants of Innovative EluNIR™ Drug-Eluting Stent

January 11, 2018 - Cordis, a Cardinal Health company, and Medinol announced that the first commercial cases using the EluNIR™ drug-eluting ...
Read More

Group Health Cooperative Eau Claire Partners with Valera Health in Innovative Behavioral Health Management

January 18, 2018 Brooklyn-based behavioural health startup Valera Health and Group Health Cooperative of Eau Claire have announced a partnership ...
Read More

JLM-BioCity Biotech Pharma startup diabetes

Oramed’s Nadav Kidron Interviewed on Las Vegas TV about their Oral Insulin Capsule

March 19, 2018 Nadav Kidron, CEO of Oramed Pharmaceuticals Inc. was recently interviewed by KTNV Channel 13 Action News on ...
Read More

Brainsway to open 8 new TMS centers with the Trinitas-St. Joseph’s Behavioral Health Network

April 4, 2017 - Brainsway will be opening 8 new TMS centers with the Trinitas-St. Joseph’s Behavioral Health Network. Trinitas-St ...
Read More

The Israeli Ministry of Health Grants Hadassah/Hadasit Laboratory Facilities GMP Compliance Status

Feb 28, 2018 - In December 2017, Israel’s Ministry of Health granted Hadassah’s Good Manufacturing Practice (GMP) biological production facility certification for ...
Read More

JLM-BioCity Hadassah Medical center GMP lab

Hadasit Signs New Research Collaboration Agreement with Genentech

February 28, 2018 - Hadasit has signed a research collaboration agreement with Genentech, a member of the Roche Group, with ...
Read More

Bio-Giv opened its New Facilities at Hebrew University’s Hitech Village on the Givat Ram Campus – Already 7 Companies Signed up!

March 14, 2018 - A small informal ceremony took place today marking the fixing of the Mezuzahs at the new ...
Read More

JLM-based Tissue Dynamics validated its groundbreaking technology with some of the world’s largest Cosmetic and Pharmaceutical companies!!

March 20, 2018 - Tissue Dynamics Ltd. validated its groundbreaking technology with some of the largest Cosmetic and Pharmaceutical companies worldwide ...
Read More

Betalin Therapeutics won second prize at the Chinese IPIEC Global 2017 competition receiving $100K award

Xi'an International Entrepreneurship Competition (abbreviated as “XIEC”) is a Chinese annual international innovation and entrepreneurship conference for cooperation and communication through ...
Read More

IsraelMinistryForeignAffairs-JLM-BioCity

Israeli Ministry of Foreign Affairs diplomatic corps cadets get a taste of the Jerusalem Bio and Life Science Innovation scene

March5, 2018 – The Israeli Ministry of Foreign Affairs cadets were given an overview of the Jerusalem Bio and Life Science Innovation ...
Read More

Teva Plant in JLM is the Right Facility to become a CDMO, this is a win-win situation for Teva and Contract Manufacturers to save an excellent crew with an excellent site.

Teva is downsizing and shedding some of its manufacturing facilities here in Israel, including two of its manufacturing facilities in ...
Read More

JLM-BioCity Orcam biomed handicapped blind

Jlm-Based Orcam Raised $ 30.4 Million at a Value of $ 1 Billion

February 20, 2018 - $1.01B: Jerusalem -based computer vision startup OrCam Technologies, which has developed a visual aid for the blind, became ...
Read More

JLM-BioCity hospital incubator entrepreneurship assistive technology

Alynnovation is Open for Entrepreneurs in Assistive Technologies for Children

March 7, 2018 ALYN Hospital has opened ALYNnovation, a commercial track that partners with entrepreneurs and inventors in developing and commercializing assistive technology products and solutions for ...
Read More

JLM-BioCity neurodeneration natural supplements

Granalix’s Pomegranate Extract is an Israeli Supplement for Preventing and Improving Neurodegenerative Diseases

February 26, 2018 - Pomegranates are known to contain powerful antioxidants that fight the oxygen free radicals that cause inflammation, ...
Read More

Ran Poliakine’s New Innovation Center is Now Open for Applications

Feb 8, 2018 - Ran Poliakine of Nveh Ilan hase just announced the launch of a brand-new innovation center that intends to ...
Read More

Prof. David Naor’s Drug Could Treat Alzheimer’s, MS, Crohn’s and More

February 11,2018 Prof. David Naor, from the Lautenberg Center for General and Tumor Immunology at the Hebrew University-Hadassah Medical School, Jerusalem, believes ...
Read More

BioCanCell Announces Updated Results from the Phase II Clinical Trial of BC-819 and BCG in Patients With Bladder Cancer

Nov. 15, 2017 (GLOBE NEWSWIRE) -- BioCancell Therapeutics (TASE:BICL), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization ...
Read More

Oramed Receives Regulatory Approval to Conduct Clinical Study for Treatment of NASH With its Oral Insulin Capsule

Nov. 14, 2017 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of ...
Read More

World first MRI for the NeoNatal ICU has been successfully working at Jerusalem’s Shaare Zedek Medical Center for the last three months

January 10, 2018 Aspect Imaging 's Embrace® dedicated Neonatal Magnetic Resonance Imaging (MRI) system has now received both the EC ...
Read More

First patients Enrolled in Immuron’s IMM-529 Clinical Study at Hadassah Medical Center in Israel

January 31, 2018 - Immuron (ASX:IMC) (NASDQ:IMRN), an Australian microbiome biopharmaceutical company focused on developing and commercializing oral immune-therapeutics for the ...
Read More

JLM-BioCity alternative medicine India cooperation

Shaare Zedek Medical Center Signs MoU with Indian Central Council for Research in Homeopathy

January 18, 2018 The Centre for Integrative Complementary Medicine of Shaare Zedek Medical Center in Jerusalem signed a pact with the Central Council for Research ...
Read More

Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as CMO

January 31, 2018 - Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC), a clinical stage biopharmaceutical company focused on developing pharmaceutical therapies based ...
Read More

The MUSE(TM) Procedure for GERD Treatment Performed First Time in Israel at Shaare-Zedek Medical Center

Dec 27, 2017 - Dr. Wengrower, Head, Therapeutic Endoscopy Unit, and his colleagues Dr. Paz and Dr. Livovsky at the ...
Read More

First Annual OurCrowd Maimonides Award for Lifetime Achievement in Science, Leadership and Menschlichkeit, was given this year to Dr. Morry Blumenfeld

Feb 1, 2018 Dr. Morry Blumenfeld, a legend in the field of medical technology development as well as MedTech investment, ...
Read More

The 2018 OurCrowd Global Investment Summit highlighted Israeli Digital Health Technologies

Feb 5, 2018 OurCrowd, one of the largest investment crowdfunding platforms in the world, held their annual summit at the International ...
Read More

Opportunities for Israeli Companies in Mexico and California

Here are the Highlights of the Cali-Israel-Mexico Innovation Expo Recruitment Presentation January 24th, 2018, Jerusalem Israel. JLM-BioCity, JBNF, Regus Co-Working ...
Read More

JLM based Entera Bio sets terms for $60m Nasdaq IPO

DNA Biomedical Solutions Ltd. (TASE: DNA) subsidiary Entera Bio has set the terms for a Nasdaq IPO to raise $50 million - $60 ...
Read More

Oramed Pharma’s CEO Issues Letter to Shareholders

Jan 19, 2017 Dear Shareholders, All the hard work and dedication in 2017 has successfully positioned Oramed to initiate a ...
Read More

OrCam Launched Next Generation of Artificial Vision for the Visually Impaired

Janaury 7, 2017 OrCam displayed their artificial vision technology, OrCam MyEye 2.0, at CES 2018. MyEye was been named a CES Innovation Awards honoree and a finalist ...
Read More

JLM based Salignostics Ltd is carrying out free saliva based pregnancy tests for a limited period of time

Dec 14, 2017 JLM based Salignostics Ltd has developed a novel pregnancy rapid home- test utilizing saliva. This is the ...
Read More

JLM-BioCity Pharma Biotech Oncology Cancer

Kitov Pharmaceuticals Announces Receipt of FDA’s Favorable Response to NT219’s pre-IND Meeting Package

Nov 11, 2017 - NT219 works by overcoming drug resistance of pancreatic cancer to various oncology drugs. Kitov Pharmaceuticals (NASDAQ: KTOV; ...
Read More

Granalix BioTechnologies, founded by Prof Ruth Gabizon, is marketing a Novel Food Additive Based On Pomegranate Oil For Protection From Neurodegenerative Diseases

Granalix BioTechnologies, following its commercial launch last year of GranaGard™ a food supplement based on pomegranate oil that was shown to prevent ...
Read More

Updated Version of Oncological Drugs Rating Tool, developed by Prof. Nathan Cherny from Shaare Zedek Medical Center

Novermber 10, 2017 The new version of an international oncological drugs rating tool, developed by Prof. Nathan Cherny from Shaare ...
Read More

JLM based Neteera Expands Market Reach and Senior Management

Dec 12, 2017: Neteera Technologies Ltd. [http://www.neteera.com ] announced the addition of Jason Rudd and Ilya Vatsel to the company's senior ...
Read More

Investors Initiate Tender Offer to Take BioCanCell Private Ahead of Planned Fundraising Round

JERUSALEM, Dec. 11, 2017 (GLOBE NEWSWIRE) -- BioCancell Therapeutics (TASE:BICL), http://www.biocancell.com/ a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of ...
Read More

Gamida Cell reports positive cancer drug trial

The company is preparing for an IPO next year, after recently raising money at a $160 million company value. Dec ...
Read More

Brainsway raises $8.5m amid record revenue growth

Dec 11, 2017 - The company awaits a response from the FDA to an application to approve its product for use ...
Read More

Gamida Cell Presents New Data from Key Programs at 2017 ASH Annual Meeting

Nov 1, 2017 - Gamida Cell, a leading cellular and immune therapeutics company based in Jerusalem, announced that two oral presentations ...
Read More

JLM-based Izun Pharmaceuticals Announces Positive Results from Phase 2 Double Blind Oral Mucositis Trial

Oct 11, 2017 - Izun Pharmaceuticals Corporation (“Izun”, “Company”, izunpharma.com), a clinical stage company focused on developing high efficacy products ...
Read More

Chemo Group Invests in Modiin Based OCON Medical

Oct 17, 2017 - Ocon Medical has developed the IUB, a proprietary intrauterine platform made of a super-elastic alloy. Global healthcare ...
Read More

NovellusDx Elected to Pitch at the Galien Annual Event in New York this week

Oct 23, 2017 - NovellusDx has been selected again by the Galien Foundation organizing committee to pitch and participate in The Galien ...
Read More

CIITECH Sponsors Research Project on Cannabis-Based Therapy for Asthma at Hebrew U’s Center on Cannabinoid Research

Oct 24, 2017 - CIITECH, a UK-Israel cannabis biotech startup, announced today that it has selected to sponsor a research project with ...
Read More

STK & Liddor Paving the way for New Biological Pipeline Production in Beit Shemesh

Oct 24 - 2017 - STK (Stockton), a leading company in the development and marketing of botanical based solutions for food ...
Read More

JLM-BioCity NimD "Cell Cure Neurosciences" "HIL Applied Medicine" "Raziel Therapetics" Pepticom "Immunovative Therapies" RenalSense NIMD

Abigail Leichman, Israel21C, Reports on 10 of the Coolest Biotech Companies in Jerusalem

September 25, 2017 - Amazing new technologies for beating conditions including breast cancer, ALS and obesity are under development in Israel’s ...
Read More

JLM-BioCity Biotech "Hebrew University" VC Jerusalem

$ 25 million investment to VC fund, Integra Holdings, who is bringing the Hebrew U’s Life Science Academic Excellence to market, led by Temasek (SIngapore)

September 27th, 2017 – Integra Holdings, an investment company exclusively focused on life science innovations originating from the Hebrew University, ...
Read More

Korea Investment Partners to finance Jlm-based Enlivex Therapeutics’s lead compound for the prevention of Graft Vs Host Disease (GVHD)

Sept 20, 2017 - Enlivex Therapeutics Ltd., a clinical stage immunotherapy company, announced today the closing of an $8 million equity financing round ...
Read More

Rosetrees Trust Interdisciplinary Prize awarded to Hebrew U scientists Yaakov Nahmias and Nir Friedman

Sept 18, 2017 - The Rosetrees Trust Interdisciplinary Prize for 2017 has been awarded to two scientists from the Hebrew University ...
Read More

JLM-based BreathVision’s Breath Volume Monitoring keeps Patients Safe in the Operating Room

Going under sedation for an operation can sometimes be riskier than the surgical procedure itself. It’s not a problem with ...
Read More

Medtronic to open development centers in Jerusalem & Yokneam in cooperation with the Israel Innovation Authority

Sept 11, 2017 - Medical equipment company Medtronic will be the first company to establish development centers in Israel in ...
Read More

JLM-BioCity Iowa Governor Kim Reynolds biomed

Iowa Economic Mission Meets Jerusalem Biotech Leaders

Jerusalem, Israel - Sept. 11, 2017 - The Iowa Economic Development Authority mission, led by Iowa Governor Kim Reynolds, met ...
Read More

JLM based Entera Bio Raising $10m at $94m Valuation

Sept 13, 2017 - Entera is developing a drug for the treatment of osteoporosis. After announcing its general plan for ...
Read More

BiondVax to Manufacture its Universal Flu Vaccine in Jerusalem!

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) signed a lease agreement for a commercial facility in Jerusalem to manufacture its universal flu ...
Read More

CellCure Invites the Public toJoin NeuroScience’s Clinical Trial To Treat Dry Age-Related Macular Degeneration

If you are over 50, and suffer from dry AMD (dry form, age-related macular degeneration), you may be eligible to ...
Read More

Brainsway’s Backlog Revenues Due to Future Lease Agreements Increased 27% to $19 Million

Aug 22 2017 - Jerusalem based Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, announced ...
Read More

New drug-testing technology from the Hebrew University could drastically cut animal testing

Aug 22 - Prof Yakov Nahmias's human-on-a-chip platform has the unique ability to predict risk of toxicity in pharma and ...
Read More

Gamida Cell Announces First Patient Transplanted in Phase 1/2 Study of CordIn for Severe Aplastic Anemia and Hypoplastic MDS

August 21, 2017 — The first subject has been transplanted in an investigator-initiated study of Cordin™ for patients with severe ...
Read More

Automatic Accurate Method for Measuring Blood Pressure Developed by Lev Academic Center (Jerusalem College of Technology)

Aug 12, 2017 - Automatic blood pressure devices are often used to assess blood pressure levels at home and in ...
Read More

HIL Applied Medical names Reno, Nevada its North American headquarters after University Collaboration

Aug 4, 2017 A continuing collaboration between Jerusalem-based HIL Applied Medical and the University of Nevada, Reno has led to ...
Read More

Oramed: On To Phase III And The Tel Aviv Stock Exchange

Aug 9 2017 - Oral Insulin Can Change the Diabetes Market Fundamentally and right now the company closest to succeeding in this ...
Read More

JLM-BioCity Oramed Simon Bruce diabetes "oral treatment" pharma

ORAMED appoints Dr. Simon Bruce as Vice President of Medical Affairs

July 18 2017 - ORAMED Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today the appointment of Dr. Simon Bruce MD ...
Read More

JLM-BioCIty Hadassit Biotech startup Cellcure

BioTime and CellCure open cGMP cell therapy manufacturing site in Israel

January 3, 2017 -BioTime and its majority-owned subsidiary, CellCure Neurosciences, opened a new, 800-m2 cGMP cell therapy manufacturing facility at the ...
Read More

Gamida Cell Announces $3.5 Million Grant from the Israeli Government

July 20 2017 - Jerusalem- based Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer ...
Read More

New partnership between Christiana Care’s Gene Editing Institute and NovellusDx aims to improve personalized cancer medicine

July 20 2017 - Personalized cancer therapies are on the horizon thanks to a new genomic cancer research partnership between the Gene ...
Read More

JLM-BioCity Biomed Orthodontics Dentistry braces

The Aerodentis braces clinical trial sheds metal brackets

The Aerodentis braces has started new clinical trials at the University of Alabama at Birmingham School of Dentistry. The treatment, called ...
Read More

JLM-BioCity AeonPharmaceuticals pharna Jerusalem biotech emergency medicine

Aeon Pharmaceuticals wins 1st place in the Pitch Competition of the Bio Executive Forum

Aeon Pharmaceuticals , a Jerusalem company, is developing a detoxification antidote to treat ER (Emergency Room) patients for alcohol poisoning. Alcohol ...
Read More

JLM-BioCity Biofeed Agritech green pesticide

BioFeed launched novel solutions for pest-control during PM’s Modi and Netanyahu visit

July 6 2017 - Biofeed launched a novel solution to the Bactrocera dorsalis and Bactrocera zonata fruit flies during a visit ...
Read More

JLM-BioCity Biodevice NIMD breast cancer therapy

Congratulations to Anan Copty, Butros Hallac, and NIMD on getting awarded a CIIRDF grant

NIMD, Non Invasive Medical Devices, a Jerusalem-based medical device startup company focused on the treatment of cancer, has been awarded ...
Read More

JLM-BioCity biotech pharma Gamida orphan genetic diseases immune therapy

Gamida Cell Ltd closes today $40 million financing!

Jerusalem based Gamida Cell Ltd., a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, ...
Read More

JLM-BioCity-Brainsway Deep-TMS treatment

Brainsway’s deep-TMS study in Obsessive Compulsive Disorder (OCD) Patients produces positive final results

Brainsway, located in Jerusalem, is preparing a submission to the FDA to market the device for Obsessive Compulsive Disorder (OCD) . Its ...
Read More